Christin Melton, ELS | Authors


High Microvascular Density in Breast Cancer May be Associated With Bevacizumab Efficacy

November 10, 2015

Findings from a recent study suggest that women whose breast cancers have a higher proportion of blood vessels may benefit more from neoadjuvant treatment with bevacizumab than women whose tumors have a lower density of blood vessels.